Observational studyPeerJ2026

Impact of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on intracranial atherosclerotic plaque characteristics and low density lipoprotein-cholesterol (LDL-C) reduction: a real-world observational study.

Zhenzhen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.